SEC Form 4 · accession 0001000229-18-000058
CORE LABORATORIES N V · CLB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martha Z. Carnes
Director
Period of report
Apr 1, 2018
Accepted (ET)
Apr 3, 2018 · 5:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001000229
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares | Apr 1, 2018 | M | 1,299 | $0.00 | A | 1,499 | D | |
| Common Shares | Apr 1, 2018 | F | 7 | $0.00 | D | 1,492 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted SharesF1 | $0.00 | Apr 1, 2018 | A | 1,387 | A | — | — | Common Shares | 1,387 | 1,387 | D |
| Restricted SharesF2 | $0.00 | Apr 1, 2018 | M | 1,299 | D | — | — | Common Shares | 1,299 | 0 | D |
Explanation of responses
- F1The Restricted Shares will vest, without performance criteria, at the end of a one-year vesting period ending April 1, 2019, subject to the terms of issuance.
- F2The Restricted Shares vested, without performance criteria, at the end of a one-year vesting period ending April 1, 2018, subject to the terms of issuance.